SCHEMBL8360672

SCHEMBL8360672

COc1ccc(S(=O)(=O)Nc2nc(-c3ccc4ccccc4c3)cs2)cc1OC

nearest known ligand 0.69

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMO O15229 1/20 0.69
MEN1 O00255 6/20 0.58
KMT2A Q03164 6/20 0.58
MAPT P10636 4/20 0.58
KDM4E B2RXH2 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
MAPK1 P28482 2/20 0.58
HTT P42858 2/20 0.58
LMNA P02545 2/20 0.58
ALDH1A1 P00352 2/20 0.58
HPGD P15428 1/20 0.58
RECQL P46063 1/20 0.58
KDM1A O60341 5/20 0.58
MAOA P21397 4/20 0.58
STAT3 P40763 1/20 0.57
AR P10275 1/20 0.56
CSNK2A1 P68400 1/20 0.55
TDP1 Q9NUW8 1/20 0.54
PKM P14618 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL728209 0.88 KDM1A (0.72) MEN1KMT2AMAPTKDM4ESMN1; SMN2
SCHEMBL8360649 0.84 KDM1A (0.66) KMOMEN1KMT2AMAPTKDM4E
SCHEMBL8356755 0.82 KDM1A (0.67) KMOMEN1KMT2AMAPTKDM4E
SCHEMBL424256 0.82 KMO (1.00) KMOMEN1KMT2AMAPTKDM4E
SCHEMBL29379527 0.82 KMO (1.00) KMOMEN1KMT2AMAPTKDM4E
SCHEMBL424785 0.81 KMO (0.87) KMOMEN1KMT2AMAPTLMNA
SCHEMBL8356715 0.78 MEN1 (0.66) KMOMEN1KMT2AMAPTKDM4E
SCHEMBL8357248 0.78 MEN1 (0.56) KMOMEN1KMT2AMAPTMAPK1
SCHEMBL12297881 0.78 ALOX5 (0.67) MEN1KMT2AMAPTKDM4ESMN1; SMN2
SCHEMBL2763474 0.77 KDM1A (0.79) MEN1KMT2AMAPTKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5877193-A NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-03-02 US claimed
US-5958910-A Use of N-(4-aryl-thiazol-2-yl)-sulfonamides HOFFMANN-LA ROCHE INC. (US) 1999-09-28 US disclosed
US-5877193-A NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-03-02 US disclosed
EP-0819681-A2 N-(4-Aryl-thiazol-2-yl)-sulfonamides and their use F. HOFFMANN-LA ROCHE AG (CH) 1998-01-21 EP disclosed